Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Other companies have developed smart insulin pens, notably Medtronic with its InPen device, but Novo Nordisk is the first to make the technology available to NHS patients in the UK. Lilly is ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

The Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value of USD 251.06 Million by 2030. In the projection period, the Global Market is forecasted ...

Discover different options for insulin delivery, from insulin pumps to smart injection pens to syringes and vials. All people with type 1 diabetes and some people with type 2 diabetes use insulin to ...

The company's Smart MDI system combines its InPen smart insulin pen with its newest Simplera CGM, the company's first disposable, all-in-one CGM that's half the size of previous Medtronic CGMs.

Companion Medical is another key player in the market, offering the InPen smart insulin pen system. The company has seen significant growth in recent years, thanks to its user-friendly design and ...

Smart insulin pens are advanced devices designed to optimize insulin delivery ... Companion Medical**, with its InPen, offers a digital insulin pen that connects with smartphone applications, making ...